Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Advanced Hematologic Cancers
NCT00042822Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2002
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), sponsored by Memorial Sloan Kettering Cancer Center. Started May 2002; status: completed.
02
Drugs
romidepsin
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00042822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042822.